Innovative Imaging Leverage SoftVue’s FDA-cleared whole breast ultrasound technology and proprietary TriAD detection to position for adjunct imaging partnerships, hospital radiology departments, and breast cancer screening centers seeking radiation-free alternatives.

Growth Financing Capitalize on recent growth funding and high-profile investment from Trinity Capital to approach venture-backed clinics and medical device distributors emphasizing scale, post-money valuation, and ongoing product development opportunities.

Leadership Talent With strategic hires like a VP of Engineering and recent Chief Medical Officer changes, offer solutions that align with R&D roadmaps and clinical adoption strategies, targeting medical affairs, clinical education, and commercialization teams.

Awards & Recognition Use Technology Breakthrough award and radiology device recognition to support collateral for buyer confidence, reimbursement discussions, and procurement pitches to imaging centers prioritizing validated innovations.

Expansion Potential Target mid-to-large radiology groups and regional health systems in the Midwest and beyond, highlighting SoftVue as a complementary modality to mammography for dense breast populations and patient experience improvements.